Connect your AI

Surgery Partners, Inc. SGRY 2029

2029 at other companies

SolventumSOLV

——

PACS GroupPACS

——

Other financials

Income statement

Revenue$810.9M+4.5%

Operating income$65.8M+6.3%

Net income-$35.9M+4.8%

EPS (diluted)-$0.28+6.7%

Balance sheet

Cash & equivalents$182.3M-20.5%

Total debt$5.1B+4.6%

Total equity$1.7B-3.0%

Total assets$8.0B+1.2%

Cash flow

Operating cash flow$11.7M+95.0%

CapEx$16.0M-29.5%

Free cash flow-$4.3M+74.3%

Valuation

Market cap$1.99B-49.1%

Profitability

Gross margin23.1%—

Operating margin11.8%+1.2pp

Net margin-2.3%-0.9pp

FCF margin6.2%+0.8pp

Returns & leverage

Return on equity-4.4%-1.6pp

Debt / equity3×+0.2×

Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive.

The official record: Surgery Partners, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s 2029.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Surgery Partners, Inc.'s 2029?: Surgery Partners, Inc. (SGRY) reported 2029 of $1.38B in Q4 2025.